---
title: "Megatrends One Year Later – #3: Human Technology Integration – What I Predicted, and What’s Actually Happening"
canonical: https://jimcarroll.com/2026/08/megatrends-one-year-later-3-human-technology-integration/
updated: 2026-08-06T19:44:07+00:00
---

# Megatrends One Year Later – #3: Human Technology Integration – What I Predicted, and What’s Actually Happening

*“When technology and human biology merge, the boundaries of what medicine can achieve completely dissolve.”* – Futurist Jim Carroll

![](https://jimcarroll.com/wp-content/uploads/2025/06/Megatrend-3-Human-Technology-Integration.jpg)

One year ago, in June 2025, I published [Megatrend #3: Human Technology Integration](https://jimcarroll.com/2025/06/decoding-tomorrow-30-megatrends-3-human-technology-integration-when-technology-and-human-biology-merge-the-boundaries-of-what-medicine-can-achieve-completely-dissolve/) as part of my 30 Megatrends series. Here’s part of what I wrote:

The boundary between technology and biology is blurring with neural interfaces, bio-monitoring, augmentation technologies, and medical device connectivity which we can refer to as bio-connectivity. It creates a new form of hyperconnected medicine, leading to entirely new categories of products, and services, not to mention ethical considerations.

I also wrote this:

Here’s where this trend takes us, in a slide from deck last week: “*The future of health isn’t just in our hands; it’s on our wrists, around our hearts, and guiding every decision. Smart, connected devices are writing a new chapter where every patient is empowered, and care is truly continuous.*”

The post was based on my many, many years of speaking about this trend, but also pulled in slides from a recent keynote for a medical device company just a few weeks before.

So where do things stand today? Broader than I gave it credit for in the first draft of this post — the bigger story isn’t brain implants, it’s the parts of bio-connectivity already in everyone’s pocket and every hospital room.

Wearable medical devices are now a $68.1 billion market in 2026, on pace for $330.5 billion by 2033 — blowing past the $37.4 billion I projected for 2028, two years ahead of my own schedule. Smartwatch penetration among adults has hit 46%; wearable adoption among patients over 50 has climbed to 34%.

The Internet of Medical Things side is scaling just as fast: smart hospitals are projected to deploy 7.4 million connected devices in 2026, up 131% from 2021, with connected medical devices alone accounting for roughly $63.7 billion of that market. And the cost-management case I made in the original post is now measured too — wearables could cut hospital costs by up to 16% over five years, and remote patient monitoring could save the health system $200 billion over 25.

Connected drug delivery moved from slide to shelf: Medtronic got FDA clearance in January for its MiniMed Go app, pairing a smart insulin pen with a continuous glucose sensor; Insulet launched an automated insulin delivery system in the Middle East in February. That’s the exact “*monitors in real-time, delivers insulin automatically”* scenario from my original slide — now shipping product, not a slide.

And yes, the neural-interface sliver of this trend is moving too: Neuralink expanded its trial to more than a dozen participants, and China approved the first commercial BCI device in March. But that’s the smallest, slowest-moving piece of a much bigger picture — no BCI is commercially available in the US yet, still research protocol only.

**Verdict: Nailed it — and undersold the wearables and IoMT side specifically.** Brain implants make the headlines. Wrists, hospital beds, and insulin pumps are where bio-connectivity actually already lives.